Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Long-Term Investments (2016 - 2025)

Healthcare Services (HCSG) has disclosed Long-Term Investments for 17 consecutive years, with $55.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Investments rose 12.63% to $55.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $55.9 million, a 12.63% increase, with the full-year FY2025 number at $55.9 million, up 12.63% from a year prior.
  • Long-Term Investments was $55.9 million for Q4 2025 at Healthcare Services, up from $55.4 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $55.9 million in Q4 2025 to a low of $31.6 million in Q3 2022.
  • A 5-year average of $43.9 million and a median of $46.4 million in 2021 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: soared 56.56% in 2021, then crashed 37.63% in 2022.
  • Healthcare Services' Long-Term Investments stood at $46.7 million in 2021, then dropped by 28.27% to $33.5 million in 2022, then rose by 21.85% to $40.8 million in 2023, then increased by 21.63% to $49.6 million in 2024, then rose by 12.63% to $55.9 million in 2025.
  • Per Business Quant, the three most recent readings for HCSG's Long-Term Investments are $55.9 million (Q4 2025), $55.4 million (Q3 2025), and $51.5 million (Q2 2025).